Company intelligence / Profile preview
CDR-Life
Schlieren/Zürich area, Switzerlandcdr-life.com ↗
- Ownership
- Private
- Employees
- ~125
- Development stage
- Preclinical
01
Overview
CDR-Life has advanced two programs into clinical testing. Its lead oncology program, CDR404—a dual MAGE-A4 T cell engager for solid tumors—entered Phase 1 trials in May 2024. Another candidate licensed to Boehringer Ingelheim for geographic atrophy (BI 771716) began a Phase 1 trial in late 2023. No published efficacy results yet; both are early-stage clinical studies focused on safety and pharmacokinetics.
- Therapeutic areas
- OphthalmologyOncologyImmunology
- Modalities
- T cell engagers (TCEs)antibody fragment-based therapeuticsMHC-targeted antibodies
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
Request access →03
Partnerships
Boehringer Ingelheim – licensing agreement for BI771716/ophthalmology programAdditional undisclosed partnerships with global pharmaceutical companies
Beyond the preview
Go deeper on CDR-Life.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CDR-Life.